Elder Pharmaceuticals Ltd vs Sun Pharmaceutical Industries Limited
A side-by-side comparison of Elder Pharmaceuticals Ltd (ELDERPHARM) and Sun Pharmaceutical Industries Limited (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Sun Pharmaceutical Industries Limited leads ELDERPHARM vs SUNPHARMA on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth01
- Size & financial health13
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
SUNPHARMA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Stock is trading at 0.11 times its book value", "Debtor days have improved from 81.3 to 60.7 days."]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 9.95% over past five years.", "Company has a low return on equity of -9.04% over last 3 years.", "Contingent liabilities of Rs.161 Cr.", "Company's cost of borrowing seems high"]
- + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
- − ["Stock is trading at 5.05 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.